Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Oct 21, 2017; 23(39): 7119-7128
Published online Oct 21, 2017. doi: 10.3748/wjg.v23.i39.7119
Table 1 Clinical characteristics of patients with biliary atresia, non-biliary atresia patients and control subjects in the retrospective study
CharacteristicBA (n = 72)Non-BA (n = 54)P value1Control (n = 38)P value2P value3
Age (d)58 ± 29 (20-180)59 ± 21 (35-125)0.8963 ± 22 (36-109)0.350.34
Male-to-female ratio31:4124:300.8819:190.490.60
Total bilirubin (μmol/L)197.6 ± 72.8163.6 ± 62.10.06219.3 ± 18.3<0.0001<0.0001
Direct bilirubin (μmol/L)132.8 ± 143.899.3 ± 50.80.295.7 ± 5.60.003<0.0001
ALT (U/L)162.9 ± 122.6170.2 ± 362.60.9121.3 ± 7.4<0.00010.15
AST (U/L)239.7 ± 156.7183.5 ± 253.10.2730.0 ± 11.1<0.00010.037
GGT(U/L)684.7 ± 450.6454.2 ± 450.90.05246.5 ± 22.4<0.00010.003
Table 2 Diagnostic value of the hepatic subcapsular spider-like telangiectasis sign in first and consensus reviews by two reviewers in the retrospective study n (%)
First review
Observer 11
Observer 22
Consistent result
Imaging featureSensitivitySpecificitySensitivitySpecificitySensitivitySpecificity
HSST72 (100)54 (100)72 (100)53 (98.1)72 (100)53 (98.1)
Table 3 Clinical characteristics of biliary atresia and non-biliary atresia patients in the validation group
CharacteristicBA (n = 45)Non-BA (n = 45)P value
Age (d)60 ± 2961 ± 230.90
Male-to-female ratio21:2425:200.40
Total bilirubin (μmol/L)192.3 ± 63.5173.6 ± 77.00.21
Direct bilirubin (μmol/L)131.6 ± 140.8104.5 ± 52.30.23
ALT (U/L)172.8 ± 120.9124.3 ± 264.10.27
AST (U/L)255.2 ± 162.1188.7 ± 193.90.08
GGT (U/L)661.8 ± 466.3320.7 ± 384.1<0.001